Advertisements


vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?

vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?.....»»

Category: topSource: seekingalphaApr 16th, 2018

Stifel Sees Challenging Road Ahead For vTv Therapeutics After Failed Alzheimer"s Trial

vTv Therapeutics Inc (NASDAQ: VTVT) announced Monday after the close that results from Part A of its late-stage study of an investigational medication to treat Alzheimer's disease did not m Latest Ratings for VTVT D.....»»

Category: blogSource: benzingaApr 10th, 2018

J&J"s Esketamine Fails to Meet Endpoint in Phase III Study

J&J's (JNJ) late-stage candidate, esketamine nasal spray, fails to show sta.....»»

Category: dealsSource: nytSep 24th, 2018

Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study

Histogenics Corp (NASDAQ: HSGX) shares were losing more than half their market value Wednesday following the release of top-line data from the Phase 3 trial of Neocar read more.....»»

Category: blogSource: benzingaSep 5th, 2018

Conatus" Emricasan Misses Primary Endpoint in Mid-Stage Study

Conatus' (CNAT) emricasan fails to meet the primary endpoint in a phase IIb study on compensated NASH cirrhosis patient.....»»

Category: dealsSource: nytDec 6th, 2018

Stocks stage comeback, Nasdaq rises after wild ride

A late day turnaround battled back the bears......»»

Category: topSource: foxnewsDec 6th, 2018

Supernus Gets Crushed Despite Positive ADHD Study Results

Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity........»»

Category: blogSource: 247wallstDec 6th, 2018

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study......»»

Category: blogSource: 247wallstNov 27th, 2018

Marijuana Stocks: GW Phamaceuticals Stock Surges on Late-Stage Study Success

InvestorPlace - Stock Market News, Stock Advice & Tra.....»»

Category: topSource: investorplaceNov 26th, 2018

Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma"s Epidiolex

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) announced incremental positive news on its lead cannabinoid product candidate Epidiolex, sending the stock higher. read more.....»»

Category: blogSource: benzingaNov 26th, 2018

Madrigal preparing for late-stage testing of experimental NASH treatment

Madrigal Pharmaceuticals presented "statistically significant" results from midstage testing of its lead new drug candidate for NASH during Monday's annual meeting of the American Association for the Study of Liver Diseases in San Francisco. The Conshoh.....»»

Category: topSource: bizjournalsNov 12th, 2018

Amarin Trades Down After Release Of Late-Stage Vascepa Trial Results

Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascep read more.....»»

Category: blogSource: benzingaNov 12th, 2018

Sarepta, Lysogene Announce Exclusive License Agreement for LYS - SAF302, a Late- stage Gene Therapy for the Treatment of MPS IIIA; Grant of Option Rights to an Additional CNS Gene Therapy Candidate

Sarepta Therapeutics, Inc. read more.....»»

Category: blogSource: benzingaOct 26th, 2018

Merrimack Fails Mid-Stage Study, But 2 Shots On Goal May Help It Redeem Itself

Merrimack Fails Mid-Stage Study, But 2 Shots On Goal May Help It Redeem Itself.....»»

Category: topSource: seekingalphaOct 22nd, 2018

vTv Therapeutics Shares Rise 50% After Setting A Date To Report Alzheimer"s Trial Results

Shares of clinical-stage pharmaceutical company¬†vTv Therapeutics Inc. (NASDAQ: VTVT) surged 50 percent Wednesday morning. read more.....»»

Category: blogSource: benzingaOct 17th, 2018

Roche Announces Positive Data on Breast Cancer Drug Kadcyla

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Category: smallbizSource: nytOct 16th, 2018

Pain Therapeutics Granted $3.5M For Alzheimer"s Study, CEO Talks Micro-Cap Volatility

Pain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma. read more.....»»

Category: blogSource: benzingaOct 4th, 2018

Why Viking Therapeutics Fatty Liver Study More Than Doubled Shares

Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial......»»

Category: blogSource: 247wallstSep 18th, 2018

Why Viking Therapeutics NAFLD Study More Than Doubled Shares

Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial......»»

Category: blogSource: 247wallstSep 18th, 2018

Why Progenics Shares Are Getting Crushed

Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study......»»

Category: blogSource: 247wallstSep 13th, 2018

Here"s Why Cara Therapeutics Rose 12.5% in August

The company announced second-quarter 2018 earnings results and initiated a crucial late-stage clinical trial......»»

Category: topSource: foxnewsSep 5th, 2018